| Company Name [desc] | Country |
|---|---|
| Orexa B.V. | Netherlands |
| Oresund Pharma ApS | Denmark |
| Oranda Therapeutics Limited | Ireland |
| Opus Materia Ltd | Greece |
| Optimal Regulatory Solutions, S.L.U. | Spain |
| OPERON, S.A. | Spain |
| Op2Lysis | France |
| OP Pharma SRL | Italy |
| Onni Biotechnologies Oy | Finland |
| Onkovis GmbH | Germany |
| Onkogen Kft. | Hungary |
| Oniria Therapeutics S.L. | Spain |
| OneChain Immunotherapeutics, S.L. | Spain |
| One-carbon Therapeutics AB | Sweden |
| OncoZenge AB | Sweden |
| Oncostellae S.L. | Spain |
| Oncoscience GmbH | Germany |
| Oncorena AB | Sweden |
| Oncoral Pharma ApS | Denmark |
| Oncopeptides AB (publ) | Sweden |
| OncoLize B.V. | Netherlands |
| Oncoinvent AS | Norway |
| Oncoheroes Biosciences Europe, S.L. | Spain |
| Oncoelectronics SAS | France |
| Oncodesign Precision Medicine | France |
| ONCO-EUROPE Kft. | Hungary |
| Ona Therapeutics | Spain |
| OmniSpirant Limited | Ireland |
| Omnicin Therapeutics BV | Netherlands |
| Omet Pharma AB | Sweden |
| Omeros Ireland Limited | Ireland |
| OMEICOS Therapeutics GmbH | Germany |
| Oloker Therapeutics srl | Italy |
| Olikla s.r.o. | Czech Republic |
| Olavide Neuron STX S.L. | Spain |
| OGD2 Pharma | France |
| Odimma Therapeutics | France |
| ODDIFACT | France |
| Oculis ehf. | Iceland |
| Ocugen Limited | Ireland |
|
|
|